Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: TI2, TechInvestorToo who wrote (3781)	12/22/2000 8:42:04 PM
From: Gary Mohilner	Respond to of 5665

Well it looks like we finally had a Santa Clause rally. With that I'd like to wish Season's Greetings to all the investors who post here, and best wishes for the New Year to all. This is especially true for the patients who are involved, or want to be involved, with ImmunoGen's drug trial, but we should also wish the best to the Doctors, Nurses, and everyone else involved with or working for the company. For long term investors this year has been good, in spite of the recent weakness. Next year has the potential of being the greatest in IMGN's history, I hope everyone remains involved. It's my belief that IMGN will report on the Multi Dose Trial, and perhaps the N901-DM1 Trial, at ASCO in May. By then I believe it will be very clear that C242-DM1 is greatly benefiting most of the patients involved in the trial. During the remainder of the year it's possible that Pivotal Expanded Phase II Trials could begin, that's not just my opinion, it's part of Mitch's presentation in Paris a few weeks ago. Bottom line, by this time next year it could be very clear that TAP Technology works, our first drug might even have be authorized for Humanitarian Usage. If I'm right, what sort of prices do you believe the stock will bring a year from now. Again, best to all for the Holiday's, Gary